Latest Breaking News On - Oral presentations - Page 1 : comparemela.com
SUZHOU, China and ROCKVILLE, Md., March 27, 2024 /PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its annual results for the full year 2023. During the reporting period, Ascentage Pharma made further strides in revenue generation through its commercialized product, achieved.
ChinaAustraliaSuzhouJiangsuCanadaPhiladelphiaPennsylvaniaUnited-statesRockvilleAmericanAscentage-pharaPrnewswire-ascentage-pharma